Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Cost of coronavirus tests varies, but high costs are exceptions

Reports of sky-high costs for coronavirus testing may be the exception, with the majority of testing being “relatively tame” in cost, according to an analysis by Axios.

Thumbnail

3 authors of controversial hydroxychloroquine study retract paper

Three authors of a research study on the efficacy of hydroxychloroquine in COVID-19 patients published in The Lancet have retracted their paper after it was met with backlash and scientific questions.

Thumbnail

Despite revenue declines, most health CFOs will invest in digital transformation

Only 12% of chief financial officers of hospital and health provider organizations say they plan to cut or defer spending on digital transformation of their financial systems despite 100% saying they expect a significant revenue decline this year due to the coronavirus.

Thumbnail

Former FDA Commissioner: COVID-19 vaccine may be seasonal

Former FDA Commissioner Scott Gottlieb expects a vaccine for the new coronavirus, COVID-19, will be seasonal, akin to a flu shot.

White House health advisor concerned coronavirus vaccine immunity won’t last forever

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Disease (NIAID) and White House public health advisor, is concerned that a potential vaccine to protect against the novel coronavirus, COVID-19, may not deliver long-term immunity.

Thumbnail

Scientists, physicians question research on hydroxychloroquine

A group consisting of 140 scientists and physicians has spoken out against a study published in The Lancet that found an association between the use of the drug hydroxychloroquine and a higher death rate among COVID-19 patients.

Thumbnail

In wake of George Floyd’s death, cardiovascular groups denounce ‘incidents of racism and violence’

The Association of Black Cardiologists, American Heart Association and American College of Cardiology have collaborated on a joint statement that touches on the death of George Floyd and its connection to the cardiovascular health of racial minorities in the United States.   

Thumbnail

Cerner names new chief technology officer

Jerome Labat has been hired as Cerner Corporation’s new chief technology officer.

Displaying 1929 - 1936 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup